CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 99 enrolled
Drug / intervention
Octave-Ultherapy treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04681352
NCT04681352N/ACompleted

Prospective, Evaluator-blind, Multicenter Study to Assess the Safety and Effectiveness of Treatment With the Octave System for Improving Lines and Wrinkles of the décolleté

Merz North America, Inc.·interventional·Posted Dec 23, 2020·Updated Jan 18, 2024

In Brief

A clinical study evaluating Octave-Ultherapy treatment for Décolleté Wrinkles. Completed, enrolled 99 participants across 10 sites.

Detailed Summary

To demonstrate the safety and effectiveness of the Octave System for improving lines and wrinkles of the décolleté.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsUlthera, Inc

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 23, 2020
Enrollment StartDec 29, 2020
Primary CompletionNov 24, 2021
Study CompletionFeb 21, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.5 years ago

Interventions

Octave-Ultherapy treatmentdevice

Micro-focused ultrasound delivered below the surface of the skin.